| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2025 3rd Quarter - Report |
VENN STRATEGIES | EMPLOYEE-OWNED S CORPORATIONS OF AMERICA | $290,000 | |
| 2024 3rd Quarter - Report |
VENN STRATEGIES | VOICES FOR NON-OPIOID CHOICES | $160,000 | |
| 2024 2nd Quarter - Report |
VENN STRATEGIES | VOICES FOR NON-OPIOID CHOICES | $40,000 | |
| 2024 1st Quarter - Report |
VENN STRATEGIES | VOICES FOR NON-OPIOID CHOICES | $60,000 | |
| 2023 4th Quarter - Report |
VENN STRATEGIES | VOICES FOR NON-OPIOID CHOICES | $10,000 | |
| 2023 3rd Quarter - Report |
VENN STRATEGIES | VOICES FOR NON-OPIOID CHOICES | $20,000 | |
| 2023 2nd Quarter - Report |
VENN STRATEGIES | VOICES FOR NON-OPIOID CHOICES | $20,000 | |
| 2023 AMENDED |
VENN STRATEGIES | VOICES FOR NON-OPIOID CHOICES | $20,000 | |
| 2023 1st Quarter - Report |
VENN STRATEGIES | VOICES FOR NON-OPIOID CHOICES | $20,000 | |
| 2022 AMENDED |
VENN STRATEGIES | VOICES FOR NON-OPIOID CHOICES | $50,000 |